Comparative Study on the Safety & Efficacy of Aspirin + Rivaroxaban vs Clopidogrel + Apixaban in Deep Vein Thrombosis Patients
  • Author(s): Neeraj Moitra
  • Paper ID: 1714291
  • Page: 1360-1362
  • Published Date: 23-02-2026
  • Published In: Iconic Research And Engineering Journals
  • Publisher: IRE Journals
  • e-ISSN: 2456-8880
  • Volume/Issue: Volume 9 Issue 8 February-2026
Abstract

Background: This research aims to evaluate and contrast the effectiveness and safety profiles of Aspirin with Rivaroxaban (RA) and Clopidogrel with Apixaban (CA) in minimizing thromboembolic risks among patients diagnosed with Deep Vein Thrombosis (DVT). Methodology: A forward-looking observational study was conducted involving 40 participants with confirmed DVT, allocated evenly between two treatment groups. Parameters assessed included recurrence and progression of DVT, bleeding events, death rates, and relevant laboratory markers. Data analysis involved Chi-square and T-tests using SPSS v26.0. Findings: The patients in the CA group had a significantly lower rate of DVT recurrence (5% vs. 45%; p= 0.0035) and a tendency towards less disease progression (10% vs. 35%; p = 0.051). The incidence of major and mild hemorrhage, as well as fatality rates, did not exhibit significant differences. However, the baseline INR, haemoglobin, and platelet count were significantly different (p<0.05) from the normal range. Conclusion: Clopidogrel-apixaban seemed to be more effective in the prevention of DVT recurrence without increasing the risk to the patients’ safety compared to Aspirin-Rivaroxaban. This study needs to be followed by broader, randomised trials to confirm these findings.

Keywords

Deep Vein Thrombosis, Dual Antithrombotic Therapy, Apixaban, Rivaroxaban, Bleeding Risk

Citations

IRE Journals:
Neeraj Moitra "Comparative Study on the Safety & Efficacy of Aspirin + Rivaroxaban vs Clopidogrel + Apixaban in Deep Vein Thrombosis Patients" Iconic Research And Engineering Journals Volume 9 Issue 8 2026 Page 1360-1362 https://doi.org/10.64388/IREV9I8-1714291

IEEE:
Neeraj Moitra "Comparative Study on the Safety & Efficacy of Aspirin + Rivaroxaban vs Clopidogrel + Apixaban in Deep Vein Thrombosis Patients" Iconic Research And Engineering Journals, 9(8) https://doi.org/10.64388/IREV9I8-1714291